4-(4-methylpiperidin-1-yl)-3-nitrobenzamide

ID: ALA5288448

Chembl Id: CHEMBL5288448

Max Phase: Preclinical

Molecular Formula: C13H17N3O3

Molecular Weight: 263.30

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CCN(c2ccc(C(N)=O)cc2[N+](=O)[O-])CC1

Standard InChI:  InChI=1S/C13H17N3O3/c1-9-4-6-15(7-5-9)11-3-2-10(13(14)17)8-12(11)16(18)19/h2-3,8-9H,4-7H2,1H3,(H2,14,17)

Standard InChI Key:  JYTMTVBQIJBDGR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5288448

    ---

Associated Targets(Human)

CTPS1 Tbio CTP synthase 1 (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 263.30Molecular Weight (Monoisotopic): 263.1270AlogP: 1.93#Rotatable Bonds: 3
Polar Surface Area: 89.47Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.96CX Basic pKa: CX LogP: 2.01CX LogD: 2.01
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.67Np Likeness Score: -1.74

References

1. Novak A, Laughton D, Lane R, Blackham E, Thomas J, Chatzopoulou E, Wrigglesworth J, Quddus A, Ahmed S, Cousin D, Duffy L, Dubois N, Unitt J, Orban K, Browne E, Ward M, Mycock D, Ieva M, Bland N, George P, Bourne T, Asnagli H, Birch L, Jones G..  (2022)  Discovery and Optimization of Potent and Orally Available CTP Synthetase Inhibitors for Use in Treatment of Diseases Driven by Aberrant Immune Cell Proliferation.,  65  (24.0): [PMID:36449304] [10.1021/acs.jmedchem.2c01446]

Source